We are focusing on the development of global new medicine.
RESEARCH & DEVELOPMENT
Incrementally Modified Drugs(IMDs)
DDS Platform
Dong-A ST is utilizing DDS platform such as New formulation, BA enhancement,
and Controlled release technology to develop IMDs that can maximize therapeutic effects.
IMDs(Incrementally Modified Drugs) are medications that have enhanced safety, efficacy, and patient compliance compared to approved drugs.
- Dosage Form Change
- Ready-to-use Injection Tech.
- Transdermal Patch & Microneedle
- Peptide oral delivery
- BA Enhancement
- Micro-emulsion
- Spray-drying Nanoparticle
- Prodrug, New Salts
- Fixed Dose Combination
- Double Layered FDC
- Multi-Layered Coating FDC
- Controlled Release
- Gastro-Retentive Technology
- Matrix and Coating System
- CR for 12hr or 24hr